戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 2) or cPLA(2) expression by their respective antisense oligodeoxyribonucleotide.
2 ls and HeLa cells to a calpain small subunit antisense oligodeoxyribonucleotide.
3 PKCdelta protein levels by PKCdelta-specific antisense oligodeoxyribonucleotides also inhibited 15-LO
4 hain product of laminin was reduced by using antisense oligodeoxyribonucleotides and DNA enzymes.
5 ions of JunD were investigated by using JunD antisense oligodeoxyribonucleotides and transient transf
6  agents such as ribozymes, antisense RNA and antisense oligodeoxyribonucleotides, and for optimizing
7 ased cPLA(2) protein expression, mediated by antisense oligodeoxyribonucleotides (AS-ODN) specific fo
8  2'-methoxyethoxy (MOE) nucleotides into the antisense oligodeoxyribonucleotide (ASO) of the heterodu
9 Raf, including small-molecule inhibitors and antisense oligodeoxyribonucleotides (ASON), are undergoi
10 -regulation of PKC epsilon protein levels by antisense oligodeoxyribonucleotides blocks MAPK activati
11 ion of the stability and conformation of the antisense oligodeoxyribonucleotides, d[CGCGTT x TTGCGC]
12 reating donor hearts with a phosphorothioate antisense oligodeoxyribonucleotide directed against Egr-
13 treating donor lungs with a phosphorothioate antisense oligodeoxyribonucleotide directed against the
14           Transfecting cortical neurons with antisense oligodeoxyribonucleotides directed against NP1
15 erapeutic interventional phase III trials of antisense oligodeoxyribonucleotides for a cancer indicat
16 eration that could be reversed by removal of antisense oligodeoxyribonucleotide from the culture medi
17                                     PKCdelta antisense oligodeoxyribonucleotides inhibited the phosph
18 oup 1 received a daily injection of TNFalpha antisense oligodeoxyribonucleotide (ODN) or control on d
19                                       Kir6.2 antisense oligodeoxyribonucleotide (ODN) was then admini
20         Although iPLA(2)beta or cPLA(2)alpha antisense oligodeoxyribonucleotide (ODN)-treated monocyt
21     We have designed a new class of modified antisense oligodeoxyribonucleotides (ODN) consisting of
22 bit individual PKC isoforms, we chose to use antisense oligodeoxyribonucleotides (ODN) to specificall
23 esents an attractive target for therapy with antisense oligodeoxyribonucleotides (ODN).
24 y involved in 15-LO expression, we generated antisense oligodeoxyribonucleotides (ODNs) against Tyk2
25 e effects of transduction with high-affinity antisense oligodeoxyribonucleotides (ODNs) designed to t
26 ffects of HER2/neu-specific phosphorothioate antisense oligodeoxyribonucleotides on HER2/neu expressi
27 epeated intracerebroventricular injection of antisense oligodeoxyribonucleotide to Kv1.1 reduces expr
28 nalysis with specific antibodies showed that antisense oligodeoxyribonucleotide to Kv1.4 microinjecte
29 Furthermore, when M21 cells transfected with antisense oligodeoxyribonucleotide to the hnRNP L RNA-bi
30                                        Using antisense oligodeoxyribonucleotide treatment we found th
31 harmacological inhibitors, PKCdelta-specific antisense oligodeoxyribonucleotides were used.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。